surmount-1 tirzepatide weight loss percent nejm 2022 for Obesity Treatment and Diabetes Prevention GLP-1 Weight Loss for Women:
Description
Ask away in the comments
Particularly relevant if you take other diabetes medications Severe injection site reaction: Extensive redness, swelling, or warmth at the injection site
doi: 10.1210/jcem.86.8.7750
Remember, what works well for one person may not be the best choice for another
While rodent studies prompted an FDA boxed warning about thyroid C-cell tumors, the relevance to humans remains unknown
Head-to-head trials showed tirzepatide achieves approximately double the weight loss of semaglutide and brings 46 percent of diabetic patients to a normal HbA1c below 5.7 percent versus 19 percent with semaglutide
